Amedeo Smart

Free Medical Literature Service


 

Amedeo

Arrhythmias

  Free Subscription

Articles published in
Am Heart J
    December 2024
  1. HAVERS-BORGERSEN E, Jons C, Butt JH, Schmidt MR, et al
    Arrhythmias in congenital heart disease: A nationwide cohort study.
    Am Heart J. 2024;278:139-149.
    >> Share

    October 2024
  2. POKORNEY SD, Nemeth H, Chiswell K, Albert C, et al
    Design and Rationale of a Pragmatic Randomized Clinical Trial of Early Dronedarone versus Usual Care to Change and Improve Outcomes in Persons with First-Detected Atrial Fibrillation - The CHANGE AFIB Study.
    Am Heart J. 2024 Oct 16:S0002-8703(24)00263-1. doi: 10.1016/j.ahj.2024.
    >> Share

    September 2024
  3. TAN A, Sreedhara SK, Russo M, Singer DE, et al
    Assessing Methods to Ascertain Persistence and Adherence of Oral Anticoagulants in Patients with Atrial Fibrillation.
    Am Heart J. 2024 Sep 18:S0002-8703(24)00237-0. doi: 10.1016/j.ahj.2024.
    >> Share

  4. LITWIN SE, Komtebedde J, Borlaug BA, Kaye DM, et al
    Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials.
    Am Heart J. 2024 Sep 3:S0002-8703(24)00216-3. doi: 10.1016/j.ahj.2024.
    >> Share

    August 2024
  5. JAIN SS, Mahaffey KW, Pieper KS, Shimizu W, et al
    Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00206-0. doi: 10.1016/j.ahj.2024.
    >> Share

  6. SANNA GD, Erre GL, Cameli M, Guerra F, et al
    Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00221-7. doi: 10.1016/j.ahj.2024.
    >> Share

  7. JIANG C, Wang Z, Du X, Wang Y, et al
    Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: rationale and design of the CRAFT trial.
    Am Heart J. 2024 Aug 23:S0002-8703(24)00203-5. doi: 10.1016/j.ahj.2024.
    >> Share

  8. REIFFEL JA
    Comparative effectiveness of monitoring duration for detection of potential or suspected arrhythmias.
    Am Heart J. 2024;274:113-114.
    >> Share

    April 2024
  9. COX J, Hamilton L, Thabane L, Foster G, et al
    Computerized Clinical Decision Support to Improve Stroke Prevention Therapy in Primary Care Management of Atrial Fibrillation: A Cluster Randomized Trial.
    Am Heart J. 2024 Apr 27:S0002-8703(24)00103-0. doi: 10.1016/j.ahj.2024.
    >> Share

  10. ELKHOLEY K, Asad ZUA, Shehata E, Mustafina I, et al
    Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum.
    Am Heart J. 2024 Apr 27:S0002-8703(24)00104-2. doi: 10.1016/j.ahj.2024.
    >> Share

  11. SAPP JL, Tang ASL, Parkash R, Stevenson WG, et al
    A Randomized Clinical Trial of Catheter Ablation and Antiarrhythmic Drug Therapy for Suppression of Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial.
    Am Heart J. 2024 Apr 20:S0002-8703(24)00096-6. doi: 10.1016/j.ahj.2024.
    >> Share

  12. KEEPANASSERIL A, Pande SN, Suriya Y, Baghel J, et al
    "Comparing the Outcomes of Rheumatic Heart Disease in Pregnancy Complicated with and without Atrial Fibrillation: A Propensity Score Matched Analysis".
    Am Heart J. 2024 Apr 11:S0002-8703(24)00089-9. doi: 10.1016/j.ahj.2024.
    >> Share

  13. TSO JV, Montalvo S, Christle J, Hadley D, et al
    Should ECG criteria for Low QRS voltage (LQRSV) be specific for Sex?
    Am Heart J. 2024;270:117-124.
    >> Share

  14. IP JE, Bui H, Camm AJ, Coutu B, et al
    Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings.
    Am Heart J. 2024;270:55-61.
    >> Share

    March 2024
  15. WU J, Nadarajah R, Nakao YM, Nakao K, et al
    Risk calculator for incident atrial fibrillation across a range of prediction horizons.
    Am Heart J. 2024 Mar 6:S0002-8703(24)00052-8. doi: 10.1016/j.ahj.2024.
    >> Share

  16. REYNOLDS MR, Passman R, Swindle J, Mohammadi I, et al
    Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries.
    Am Heart J. 2024;269:25-34.
    >> Share

  17. RODRIGUEZ MUNOZ D, Ramos Jimenez J, Marco Del Castillo A, Lozano Granero C, et al
    Symptom burden guiding invasive electrophysiological study in paroxysmal supraventricular tachycardia: The believe SVT registry.
    Am Heart J. 2024;269:15-24.
    >> Share

    February 2024
  18. LEE SH, Lee SJ, Heo JH, Ahn SG, et al
    Optimal antithrombotic strategy in patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation: Design and rationale of the randomized ADAPT AF-DES trial.
    Am Heart J. 2024 Feb 22:S0002-8703(24)00041-3. doi: 10.1016/j.ahj.2024.
    >> Share

  19. JONES ID, Lane DA, Lotto RR, Oxborough D, et al
    Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study.
    Am Heart J. 2024 Feb 21:S0002-8703(24)00038-3. doi: 10.1016/j.ahj.2024.
    >> Share

    January 2024
  20. CAPPATO R, Mark DB, Silverstein AP, Noseworthy PA, et al
    Regional Differences in Outcomes with Ablation Versus Drug Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Am Heart J. 2024 Jan 31:S0002-8703(24)00018-8. doi: 10.1016/j.ahj.2024.
    >> Share

  21. BURNS B, Marschner I, Eggins R, Buscher H, et al
    A randomized trial of expedited intra-arrest transfer versus more extended on-scene resuscitation for refractory out of hospital cardiac arrest: Rationale and design of the EVIDENCE trial.
    Am Heart J. 2024;267:22-32.
    >> Share

    December 2023
  22. KANTHASAMY V, Schilling R, Zongo O, Khan K, et al
    Feasibility of Double-Blinded, Placebo-Controlled Interventional Study for Assessing Catheter Ablation Efficacy in Persistent Atrial Fibrillation: Insights from the ORBITA AF Feasibility study.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00353-8. doi: 10.1016/j.ahj.2023.
    >> Share

  23. CHEN X, Luo G, Li H, Zheng J, et al
    High prevalence and distinctive clinical features of LMNA-associated atrioventricular block in young patients.
    Am Heart J. 2023 Dec 2:S0002-8703(23)00328-9. doi: 10.1016/j.ahj.2023.
    >> Share

    November 2023
  24. SWOJANOWSKY P, Bundis-Dimitrijevic M, Ha CSR, von Korn H, et al
    Rationale and design of the VAST-AF trial: A randomized controlled, blinded, clinical trial to evaluate transcutaneous vagal nerve stimulation for the prevention of persistent atrial fibrillation recurrence.
    Am Heart J. 2023 Nov 30:S0002-8703(23)00325-3. doi: 10.1016/j.ahj.2023.
    >> Share

  25. CHUI PW, Khokhar A, Gordon KS, Dziura J, et al
    Opioid Prescription and Risk of Atrial Fibrillation in Younger Veterans: Opioid Use and Risk of Atrial Fibrillation.
    Am Heart J. 2023 Nov 8:S0002-8703(23)00310-1. doi: 10.1016/j.ahj.2023.
    >> Share

    October 2023
  26. YAO X, Attia ZI, Behnken EM, Hart MS, et al
    Realtime Diagnosis from Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation with Long Follow-Up (REGAL): Rationale and design of a pragmatic, decentralized, randomized controlled trial.
    Am Heart J. 2023 Oct 30:S0002-8703(23)00298-3. doi: 10.1016/j.ahj.2023.
    >> Share

    September 2023
  27. FLETT A, Cebula A, Nicholas Z, Adam R, et al
    Rationale and study protocol for the BRITISH randomised trial (Using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with Non-Ischaemic Cardiomyopathy and
    Am Heart J. 2023 Sep 28:S0002-8703(23)00281-8. doi: 10.1016/j.ahj.2023.
    >> Share

  28. EGBE AC, Miranda WR, Madhavan M, Abozied O, et al
    Right atrial dysfunction is associated with atrial arrhythmias in adults with repaired tetralogy of fallot.
    Am Heart J. 2023;263:141-150.
    >> Share

    August 2023
  29. BISSON A, Lemrini Y, Romiti GF, Proietti M, et al
    Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study.
    Am Heart J. 2023 Aug 16:S0002-8703(23)00203-X. doi: 10.1016/j.ahj.2023.
    >> Share

  30. L'HOYES W, Robyns T, Moura-Fereira S, De Meester P, et al
    Effectiveness of the Risk Stratification Proposed by the 2022 European Heart Rhythm Association Expert Consensus Statement on Arrhythmic Mitral Valve Prolapse.
    Am Heart J. 2023 Aug 16:S0002-8703(23)00201-6. doi: 10.1016/j.ahj.2023.
    >> Share

  31. KIR D, Van Houten HK, Walvatne KN, Behnken EM, et al
    Physicians' Perspectives on Percutaneous Left Atrial Appendage Occlusion for Patients with Atrial Fibrillation.
    Am Heart J. 2023 Aug 9:S0002-8703(23)00184-9. doi: 10.1016/j.ahj.2023.
    >> Share

  32. DEMKOWICZ PC, Dhruva SS, Spatz ES, Beatty AL, et al
    Physician responses to apple watch-detected irregular rhythm alerts.
    Am Heart J. 2023;262:29-37.
    >> Share

    July 2023
  33. VINEREANU D, Wojdyla DM, Alexander JH, Lopes RD, et al
    Heart Rate and Death and Hospitalization for Heart Failure in Patients with Persistent or Permanent Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Am Heart J. 2023 Jul 26:S0002-8703(23)00179-5. doi: 10.1016/j.ahj.2023.
    >> Share

  34. PIPILAS DC, Khurshid S, Atlas SJ, Ashburner JM, et al
    Accuracy and Variability of Cardiologist Interpretation of Single Lead Electrocardiograms for Atrial Fibrillation: the VITAL-AF Trial.
    Am Heart J. 2023 Jul 12:S0002-8703(23)00173-4. doi: 10.1016/j.ahj.2023.
    >> Share

  35. UHE T, Wasser K, Weber-Kruger M, Schabitz WR, et al
    Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism - the Find-AF 2 study - Rationale and design.
    Am Heart J. 2023 Jul 6:S0002-8703(23)00171-0. doi: 10.1016/j.ahj.2023.
    >> Share

    June 2023
  36. LOPES RD, de Barros E Silva PGM, Filho CRH, Cavalvante MA, et al
    The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study.
    Am Heart J. 2023 Jun 15:S0002-8703(23)00162-X. doi: 10.1016/j.ahj.2023.
    >> Share

  37. MADSEN CL, Park-Hansen J, Irmukhamedov A, Carranza CL, et al
    The Left Atrial Appendage Closure by Surgery-2 (LAACS-2) trial protocol Rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of pre
    Am Heart J. 2023 Jun 9:S0002-8703(23)00147-3. doi: 10.1016/j.ahj.2023.
    >> Share

  38. VIRTANEN JK, Hantunen S, Lamberg-Allardt C, Manson JE, et al
    The effect of vitamin D(3) supplementation on atrial fibrillation in generally healthy men and women -the Finnish Vitamin D Trial.
    Am Heart J. 2023 Jun 9:S0002-8703(23)00143-6. doi: 10.1016/j.ahj.2023.
    >> Share

  39. KAR S, Doshi SK, Alkhouli M, Camm AJ, et al
    Rationale and Design of a Randomized Study Comparing the Watchman FLX Device to DOACs in Patients with Atrial Fibrillation.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00140-0. doi: 10.1016/j.ahj.2023.
    >> Share

    April 2023
  40. RAO VN, Cyr D, Wruck L, Sanders G, et al
    Electronic Health Record Characterization and Outcomes of Heart Failure with Preserved Ejection Fraction.
    Am Heart J. 2023 Apr 26:S0002-8703(23)00100-X. doi: 10.1016/j.ahj.2023.
    >> Share

  41. PUNDI K, Perino AC, Fan J, Din N, et al
    Association of CHA(2)DS(2)-VASc and HAS-BLED to Frailty and Frail Outcomes: From the TREAT-AF Study.
    Am Heart J. 2023 Apr 4:S0002-8703(23)00076-5. doi: 10.1016/j.ahj.2023.
    >> Share

  42. MILLS EW, Cassidy M, Sofer T, Tadros T, et al
    Evaluation of obstructive sleep apnea among consecutive patients with all patterns of atrial fibrillation using WatchPAT home sleep testing.
    Am Heart J. 2023 Apr 3:S0002-8703(23)00074-1. doi: 10.1016/j.ahj.2023.
    >> Share

    March 2023
  43. HIJAZI Z, Lindback J, Oldgren J, Benz AP, et al
    Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores.
    Am Heart J. 2023 Mar 27:S0002-8703(23)00073-X. doi: 10.1016/j.ahj.2023.
    >> Share

  44. RONG LQ, Franco AD, Rahouma M, Dimagli A, et al
    Postoperative pericardial effusion, pericardiotomy and atrial fibrillation: an explanatory analysis of the PALACS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00063-7. doi: 10.1016/j.ahj.2023.
    >> Share

  45. SUDO Y, Morimoto T, Tsushima R, Sogo M, et al
    P-wave Terminal Force in Lead V1 and Outcomes in Patients with Persistent Atrial Fibrillation Undergoing Catheter Ablation.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00066-2. doi: 10.1016/j.ahj.2023.
    >> Share

  46. NGUFOR C, Yao X, Inselman JW, Ross JS, et al
    Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method.
    Am Heart J. 2023 Mar 7:S0002-8703(23)00049-2. doi: 10.1016/j.ahj.2023.
    >> Share

    February 2023
  47. LIU XX, Liu Q, Lai YW, Guo Q, et al
    Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design.
    Am Heart J. 2023 Feb 20:S0002-8703(23)00027-3. doi: 10.1016/j.ahj.2023.
    >> Share

  48. CONEN D, Popova E, Wang MK, Chan MTV, et al
    Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00025-X. doi: 10.1016/j.ahj.2023.
    >> Share

    January 2023
  49. GOMEZ SE, Parizo J, Ermakov S, Larson J, et al
    Evaluation of the Association Between Circulating IL-1beta and Other Inflammatory Cytokines and Incident Atrial Fibrillation in a Cohort of Postmenopausal Women.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00011-X. doi: 10.1016/j.ahj.2023.
    >> Share

  50. GIBSON CM, Steinhubl S, Lakkireddy D, Turakhia MP, et al
    Does Early Detection of Atrial Fibrillation Reduce the Risk of Thromboembolic Events? Rationale and Design of the Heartline Study.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00014-5. doi: 10.1016/j.ahj.2023.
    >> Share

    December 2022
  51. LOPEZ-GALVEZ R, Rivera-Caravaca JM, Roldan V, Orenes-Pinero E, et al
    Imaging in atrial fibrillation: a way to assess atrial fibrosis and remodeling to assist decision-making.
    Am Heart J. 2022 Dec 13:S0002-8703(22)00329-5. doi: 10.1016/j.ahj.2022.
    >> Share

  52. HARRISON SL, Buckley BJR, Zheng Y, Hill A, et al
    Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00324-6. doi: 10.1016/j.ahj.2022.
    >> Share

  53. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    >> Share

    November 2022
  54. STAMBLER BS, Plat F, Sager PT, Lubkov V, et al
    Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia.
    Am Heart J. 2022;253:20-29.
    >> Share

    September 2022
  55. ZEITLER EP, Bunch TJ, Khanna R, Fan X, et al
    Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs.
    Am Heart J. 2022;254:194-202.
    >> Share

  56. BRIK T, Lucassen WAM, Harskamp RE, Karregat EPM, et al
    Personalized approach using wearable technology for early detection of Atrial Fibrillation in high-risk primary care patients (PATCH-AF): study protocol for a cluster randomized controlled trial.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00185.
    >> Share

  57. NAKAMARU R, Ikemura N, Spertus JA, Kimura T, et al
    Rate versus Rhythm Control in Patients with Newly Diagnosed Atrial Fibrillation: Effects of the Treatment Timing on Health Status Outcomes.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00187.
    >> Share

    August 2022
  58. NERY PB, Wells GA, Verma A, Joza J, et al
    CHARACTERIZATION OF ARRHYTHMIA SUBSTRATE TO ABLATE PERSISTENT ATRIAL FIBRILLATION (COAST-AF): RANDOMIZED CONTROLLED TRIAL DESIGN AND RATIONALE.
    Am Heart J. 2022 Aug 25. pii: S0002-8703(22)00181.
    >> Share

  59. FRIEDMAN DJ, Pierre D, Wang Y, Gambone L, et al
    Development and Validation of an Automated Algorithm for Endpoint Adjudication for a Large U.S. National Registry: Short Title: Automated Adjudication Algorithm.
    Am Heart J. 2022 Aug 22. pii: S0002-8703(22)00168.
    >> Share

  60. MURRAY EM, Greene SJ, Rao VN, Sun JL, et al
    Machine Learning to Define Phenotypes and Outcomes of Patients Hospitalized for Heart Failure with Preserved Ejection Fraction: Findings from ASCEND-HF.
    Am Heart J. 2022 Aug 22. pii: S0002-8703(22)00171.
    >> Share

    July 2022
  61. SCHOLTEN J, Jansen WPJ, Horsthuis T, Mahes AD, et al
    Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection.
    Am Heart J. 2022 Jul 15. pii: S0002-8703(22)00143.
    >> Share

  62. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
    Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
    Am Heart J. 2022 Jul 11. pii: S0002-8703(22)00145.
    >> Share

    June 2022
  63. DIXON D, Patel J, Spence R, Talasaz A, et al
    Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review.
    Am Heart J. 2022 Jun 14. pii: S0002-8703(22)00126.
    >> Share

  64. MAGNANI JW, Ferry D, Swabe G, Martin D, et al
    Design and rationale of the Mobile health intervention for rural atrial fibrillation.
    Am Heart J. 2022 Jun 9. pii: S0002-8703(22)00117.
    >> Share

  65. REIFFEL JA
    The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
    Am Heart J. 2022;248:163-164.
    >> Share

    May 2022
  66. AULIN J, Hijazi Z, Lindback J, Alexander JH, et al
    Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multistate model.
    Am Heart J. 2022 May 12. pii: S0002-8703(22)00091.
    >> Share

  67. OKAZAKI O, Higashino Y, Yokoya K, An Y, et al
    Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis.
    Am Heart J. 2022 May 11. pii: S0002-8703(22)00094.
    >> Share

  68. GWAG HB, Kim HR, Park SJ, Kim J, et al
    The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a p
    Am Heart J. 2022 May 11. pii: S0002-8703(22)00090.
    >> Share

  69. LOPEZ-GALVEZ R, Marin F, Rivera-Caravaca JM
    Predicting heart failure in atrial fibrillation patients: What about using biomarkers?
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00092.
    >> Share

  70. HUIJBOOM HFM, Maarse M, Aarnink E, van Dijk VF, et al
    COMPARE LAAO: Rationale and design of the randomized controlled trial 'COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagul
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00085.
    >> Share

  71. WAZNI O, Boersma L, Healey JS, Mansour M, et al
    Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation: Rationale and Design of the OPTION randomized trial.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00088.
    >> Share

  72. GAO W, Zhong X, Ma Y, Huang D, et al
    A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
    >> Share

    April 2022
  73. SINGER DE, Atlas SJ, Go AS, Lopes RD, et al
    ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and Design of the GUARD-AF Randomized Trial of Screening for Atrial Fibrillation with a 14-day Patch-Based Continuous ECG Monitor.
    Am Heart J. 2022 Apr 23. pii: S0002-8703(22)00080.
    >> Share

    February 2022
  74. NAIR GM, Birnie DH, Wells GA, Nery PB, et al
    Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence (AWARE) Trial: Design and Rationale.
    Am Heart J. 2022 Feb 24. pii: S0002-8703(22)00043.
    >> Share

  75. JONES AE, McCarty MM, Brito JP, Noseworthy PA, et al
    Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation: Rationale and Design of the RED-AF study.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00042.
    >> Share

  76. CHO MS, Kang DY, Oh YS, Lee CH, et al
    Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
    >> Share

  77. CHANG PC, Wen MS, Chou CC, Wang CC, et al
    Atrial Fibrillation Detection Using Ambulatory Smartwatch Photoplethysmography and Validation with Simultaneous Holter Recording.
    Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00028.
    >> Share

    January 2022
  78. BAYKANER T, Pundi K, Lin B, Lu Y, et al
    The ENHANCE-AF Clinical Trial to Evaluate an Atrial Fibrillation Shared Decision-Making Pathway: Rationale and Study Design.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00013.
    >> Share

  79. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
    Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
    >> Share

  80. ECKMAN MH, Wise R, Knochelmann C, Mardis R, et al
    Electronic Health Record-Embedded Decision Support to Reduce Stroke Risk in Patients with Atrial Fibrillation - Study Protocol.
    Am Heart J. 2022 Jan 23. pii: S0002-8703(22)00012.
    >> Share

  81. GENCER B, Eisen A, Berger D, Nordio F, et al
    Edoxaban vs. Warfarin in High-risk Patients with Atrial Fibrillation: A Comprehensive Analysis of High-Risk Subgroups.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00499.
    >> Share

  82. FARJAT AE, Virdone S, Thomas LE, Kakkar AK, et al
    The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries.
    Am Heart J. 2022;243:110-121.
    >> Share

    December 2021
  83. HIGGINS AY, Annapureddy AR, Wang Y, Minges KE, et al
    Risk and Predictors of Mortality After Implantable Cardioverter-Defibrillator Implantation in Patients with Sarcoid Cardiomyopathy.
    Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00491.
    >> Share

  84. ULLAL AJ, Holmes DN, Lytle BL, Matsouaka RA, et al
    Achievement and Quality Measure Attainment in Patients Hospitalized with Atrial Fibrillation: Results from the Get With The Guidelines(R) - Atrial Fibrillation (GWTG-AFIB) Registry.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00475.
    >> Share

  85. PAVLOVIC N, Chierchia GB, Velagic V, Hermida JS, et al
    Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms.
    Am Heart J. 2021;242:103-114.
    >> Share

    November 2021
  86. STEINBERG BA, Li Z, Shrader P, Chew DS, et al
    Clinical Investigations Bimodal Distribution of Atrial Fibrillation Burden in 3 Distinct Cohorts: What is 'Paroxysmal' Atrial Fibrillation?
    Am Heart J. 2021 Nov 24. pii: S0002-8703(21)00464.
    >> Share

  87. ANTONIO GUTIERREZ J, Ruff CT, Aday AW, Gu L, et al
    Electronic Alerts to Initiate Anticoagulation Dialogue in Patients with Atrial Fibrillation.
    Am Heart J. 2021 Nov 19. pii: S0002-8703(21)00452.
    >> Share

  88. CHEW DS, Li Z, Steinberg BA, O'Brien E, et al
    Association between Economic and Arrhythmic Burden of Paroxysmal Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices.
    Am Heart J. 2021 Nov 17. pii: S0002-8703(21)00450.
    >> Share

  89. MERT GO, Babayigit E, Gorenek B
    The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
    Am Heart J. 2021;241:121.
    >> Share

  90. TOMASDOTTIR M, Held C, Wallentin L, Hijazi Z, et al
    Natriuretic peptides and incident atrial fibrillation.
    Am Heart J. 2021;241:120.
    >> Share

  91. DAILEY-SCHWARTZ AL, Dyal JA, Mahle WT, Oster ME, et al
    Implementation of a practice plan for the outpatient cardiac evaluation of children after acute SARS-CoV-2 infection and a report of outcomes.
    Am Heart J. 2021;241:83-86.
    >> Share

    October 2021
  92. AKDIS D, Chen L, Saguner AM, Zhang N, et al
    Novel Plasma Biomarkers Predicting Biventricular Involvement in Arrhythmogenic Right Ventricular Cardiomyopathy: Novel Biomarkers in ARVC.
    Am Heart J. 2021 Oct 28. pii: S0002-8703(21)00441.
    >> Share

  93. ARITA VA, Santema BT, De With RR, Nguyen BO, et al
    Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: data from the AF-RISK study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00435.
    >> Share

  94. PICCINI JP, Ahlsson A, Dorian P, Gillinov MA, et al
    Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
    Am Heart J. 2021 Oct 20. pii: S0002-8703(21)00366.
    >> Share

  95. RASMUSSEN PV, Blanche P, Dalgaard F, Gislason GH, et al
    Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic events: Rasmussen et al: Electrical cardioversion and bradycardia.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00434.
    >> Share

  96. CHIENG D, Sugumar H, Ling LH, Segan L, et al
    Catheter Ablation for Persistent Atrial Fibrillation: a Multicentre Randomised Trial of Pulmonary Vein Isolation (PVI) versus PVI with Posterior Left Atrial Wall Isolation (PWI) - the CAPLA Study: CAPLA: randomised trial for persistent AF.
    Am Heart J. 2021 Oct 4. pii: S0002-8703(21)00245.
    >> Share

    September 2021
  97. KORSHOLM K, Damgaard D, Valentin JB, Packer EJS, et al
    Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Rationale and Design of the Multicenter Randomized Occlusion-AF Trial.
    Am Heart J. 2021 Sep 16. pii: S0002-8703(21)00226.
    >> Share

  98. BURNHAM TS, May HT, Bair TL, Anderson JA, et al
    Long-term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease.
    Am Heart J. 2021 Sep 16. pii: S0002-8703(21)00211.
    >> Share

  99. KIM K, Yang PS, Jang E, Yu HT, et al
    Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study.
    Am Heart J. 2021 Sep 1. pii: S0002-8703(21)00224.
    >> Share

    August 2021
  100. DAWWAS GK, Barnes GD, Dietrich E, Cuker A, et al
    Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation A population-based analysis.
    Am Heart J. 2021 Aug 24. pii: S0002-8703(21)00212.
    >> Share

  101. BONNESEN MP, Diederichsen SZ, Isaksen JL, Frederiksen KS, et al
    Atrial Fibrillation Burden and Cognitive Decline in Elderly Patients Undergoing Continuous Monitoring.
    Am Heart J. 2021 Aug 21. pii: S0002-8703(21)00204.
    >> Share

  102. HAWKINS NM, Er L, Sandhu RK, Kaul P, et al
    Validity of different dose reduction criteria for apixaban.
    Am Heart J. 2021;238:12-15.
    >> Share

    July 2021
  103. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
    Admission Rates During a Second COVID-19 Lockdown.
    Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
    >> Share

  104. FREYER L, von Stulpnagel L, Spielbichler P, Sappler N, et al
    Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based Bavarian Alternative Detection of Atrial Fibrillation (eBRAVE-AF) trial.
    Am Heart J. 2021 Jul 9. pii: S0002-8703(21)00164.
    >> Share

    June 2021
  105. KUMAR N, Xu H, Garg N, Pandey A, et al
    Patient Characteristics, Care Patterns, and Outcomes of Atrial Fibrillation Associated Hospitalizations in Patients with Chronic Kidney Disease and End-Stage Renal Disease.
    Am Heart J. 2021 Jun 30. pii: S0002-8703(21)00175.
    >> Share

  106. WHEELOCK KM, Kratz A, Lathkar-Pradhan S, Najarian K, et al
    Association between Symptoms, Affect and Heart Rhythm in Patients with Persistent or Paroxysmal Atrial Fibrillation: An Ambulatory Pilot Study.
    Am Heart J. 2021 Jun 19. pii: S0002-8703(21)00150.
    >> Share

  107. SZUMMER K, Perino AC, Fan J, Kothari M, et al
    Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices.
    Am Heart J. 2021 Jun 9. pii: S0002-8703(21)00149.
    >> Share

    May 2021
  108. KITTIPIBUL V, Blumer V, Hernandez GA, Fudim M, et al
    Pre-operative Atrial Fibrillation and Early Right Ventricular Failure after Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis.
    Am Heart J. 2021 May 23. pii: S0002-8703(21)00138.
    >> Share

  109. YAO X, Attia ZI, Behnken EM, Walvatne K, et al
    Batch Enrollment for an Artificial Intelligence-Guided Intervention to Lower Neurologic Events in Patients with Undiagnosed Atrial Fibrillation (BEAGLE): Rationale and design of a digital clinical trial.
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00135.
    >> Share

  110. HESS PL, Gosch KL, Jani SM, Varosy PD, et al
    Use of Oral Anticoagulants in Patients with Valvular Atrial Fibrillation: Findings From the NCDR PINNACLE Registry(R).
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00120.
    >> Share

  111. GRUBB CS, Truby LK, Topkara VK, Bohnen MS, et al
    Advanced Heart Failure Patients Supported with Ambulatory Inotropic Therapy: What Defines Success of Therapy?
    Am Heart J. 2021 May 10. pii: S0002-8703(21)00121.
    >> Share

  112. MADSEN JMM, Jacobsen MRR, Sabbah M, Topal DGG, et al
    Long-Term Prognostic Outcomes and Implication of Oral Anticoagulants in Patients with New-Onset Atrial Fibrillation following ST-Segment Elevation Myocardial Infarction.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00114.
    >> Share

    April 2021
  113. LUBITZ SA, Faranesh AZ, Atlas SJ, McManus DD, et al
    Rationale and Design of a Large Population Study to Validate Software for the Assessment of Atrial Fibrillation from Data Acquired by a Consumer Tracker or Smartwatch: The Fitbit Heart Study.
    Am Heart J. 2021 Apr 15. pii: S0002-8703(21)00093.
    >> Share

  114. MARTIN AC, Hausleiter J, Karam N
    Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures.
    Am Heart J. 2021;234:136-137.
    >> Share

    March 2021
  115. KIVINIEMI T, Bustamante-Munguira J, Olsson C, Jeppsson A, et al
    A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol.
    Am Heart J. 2021 Mar 30. pii: S0002-8703(21)00087.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016